Trial Search Results
Showing 1 - 20 of 1893 trials
-
Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
Stanford is currently accepting patients for this trial. -
A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors
Stanford is currently accepting patients for this trial. -
Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin
Stanford is currently accepting patients for this trial. -
Clinical Trial of a Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies
Stanford is currently accepting patients for this trial. -
Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS)
Stanford is currently accepting patients for this trial. -
Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer
Stanford is currently accepting patients for this trial. -
A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors
Stanford is currently accepting patients for this trial. -
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Stanford is currently accepting patients for this trial. -
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
Stanford is currently accepting patients for this trial. -
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
Stanford is currently accepting patients for this trial. -
Study of Sacituzumab Govitecan-hziy Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) Without Actionable Genomic Alterations
Stanford is currently accepting patients for this trial. -
Dose Escalation Study of CLR 131 in Children, Adolescents, and Young Adults With Relapsed or Refractory Malignant Tumors Including But Not Limited to Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma
Stanford is currently accepting patients for this trial. -
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Stanford is currently accepting patients for this trial. -
A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors
Stanford is currently accepting patients for this trial. -
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
Stanford is currently accepting patients for this trial. -
Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors
Stanford is currently accepting patients for this trial. -
Safety and Efficacy of Repeat Administration of Ad/PNP and Fludarabine Phosphate in Patients With Local Head/Neck Cancer
Stanford is currently accepting patients for this trial. -
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules
Stanford is currently accepting patients for this trial. -
Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck
Stanford is currently accepting patients for this trial. -
Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
Stanford is currently accepting patients for this trial.